New patch could ease agitation in Alzheimer's patients
Symptom relief
Recruiting now
This study tests a medicated skin patch (dexmedetomidine) to see if it can reduce agitation in people with Alzheimer's dementia. About 150 participants living in care facilities will receive either the patch or a placebo for 96 hours. The goal is to measure changes in agitated be…
Phase: PHASE2 • Sponsor: Teikoku Pharma USA, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC